Guidance

Tuberculosis (TB): Interferon Gamma Release Assay tests

The use of Interferon Gamma Release Assay (IGRA) testing for Tuberculosis (TB).

Document

Position statement on the use of Interferon Gamma Release Assay tests for Tuberculosis

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This document is a response to the 2011 guidance from the National Institute for Health and Care Excellence (NICE) on Interferon Gamma Release Assay tests.

Published 19 July 2013